Catalog
Client
Currency:
+380 66 708 47 52
Our location:
Ternopil city
Phones:
E-mail
august.levinskii@yahoo.com
We are on social networks
Go to contacts
0 0
Catalog
Main page
Wishlist
0
Compare
0
Contacts

Xavron solution for injection 1.5 mg/ml ampoule 20 ml No. 2

SKU: an-1049369
0
All about product
Description
Specification
Reviews 0
Questions0
new
Hit
Xavron solution for injection 1.5 mg/ml ampoule 20 ml No. 2
Xavron solution for injection 1.5 mg/ml ampoule 20 ml No. 2
Xavron solution for injection 1.5 mg/ml ampoule 20 ml No. 2
Xavron solution for injection 1.5 mg/ml ampoule 20 ml No. 2
In Stock
998.88 грн.
Buy this product in 1 click:
Active ingredient:Edaravon
Adults:Can
ATC code:N AGENTS ACTING ON THE NERVOUS SYSTEM; N07 OTHER AGENTS ACTING ON THE NERVOUS SYSTEM; N07X OTHER AGENTS ACTING ON THE NERVOUS SYSTEM; N07X X Other agents acting on the nervous system
Country of manufacture:Ukraine
Diabetics:Can
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Xavron solution for injection 1.5 mg/ml ampoule 20 ml No. 2
998.88 грн.
Description

Xavron injection solution is indicated for:

Alleviation of neurological symptoms, manifestations of impairments in activities of daily living and functional disorders associated with acute ischemic stroke. Slowing the progression of functional disorders in patients with amyotrophic lateral sclerosis.

Composition

Active ingredient: edaravone;

1 ml of 1.5 mg of edaravone;

Excipients: sodium metabisulfite (E 223), sodium chloride, sodium hydroxide, phosphoric acid, water for injections.

Contraindication

Severe renal failure.

Hypersensitivity to the components of the drug.

Method of application

Neurological symptoms associated with acute ischemic stroke, manifestations of impairment of daily activities, relief of various types of dysfunctions: 30 mg of edaravone (1 ampoule) twice a day, morning and evening, by infusion over 30 minutes. Before administration, the contents of the ampoule are dissolved in 100 ml of 0.9% sodium chloride. Therapy should be started within 24 hours after the onset of symptoms, the duration of treatment is at least 14 days.

Application features

Pregnant women

Not recommended for use.

Drivers

The drug is intended for use in a hospital setting.

Overdose

Cases of overdose have not been described.

Side effects

From the urinary system: acute renal failure, nephrotic syndrome. From the skin: rash, redness, edema, itching, erythema. From the digestive system: liver dysfunction, hepatic failure, fulminant hepatitis, jaundice. From the nervous system: insomnia, headache. From the cardiovascular system: increased blood pressure. From the blood: agranulocytosis, DIC syndrome, decreased red blood cell count, leukocytosis, leukopenia, decreased hematocrit, decreased hemoglobin, thrombocytosis, thrombocytopenia. From the respiratory system: acute lung injury syndrome, accompanied by pyrexia, cough, shortness of breath, chest X-ray abnormalities. From the gastrointestinal tract: nausea, vomiting. From the musculoskeletal system: rhabdomyolysis. On the part of the immune system: shock, anaphylactic shock (urticaria, decreased blood pressure, difficulty breathing, etc.).

Interaction

When used simultaneously with antibiotics with a renal type of excretion (cefazolin sodium, cefotiam hydrochloride, piperacillin sodium, etc.), there is a possibility of increased renal dysfunction; in the case of combined use, careful observation should be carried out, regularly analyzing renal function.

Storage conditions

Store at a temperature not exceeding 25 °C in the original packaging.

Keep out of reach of children.

Shelf life - 2 years.

Specifications
Characteristics
Active ingredient
Edaravon
Adults
Can
ATC code
N AGENTS ACTING ON THE NERVOUS SYSTEM; N07 OTHER AGENTS ACTING ON THE NERVOUS SYSTEM; N07X OTHER AGENTS ACTING ON THE NERVOUS SYSTEM; N07X X Other agents acting on the nervous system
Country of manufacture
Ukraine
Diabetics
Can
Dosage
1.5 mg/ml
Drivers
Data not available, only applicable in hospital settings
For allergies
With caution
For children
It is impossible.
Form
Ampoules for infusions
Method of application
Injections
Nursing
It is impossible.
Pregnant
It is impossible.
Primary packaging
ampoule
Producer
Yuria-Pharm LLC
Quantity per package
2 ampoules
Trade name
Xavron
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

998.88 грн.